Mystic Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.88M Buy
20,879
+26
+0.1% +$4.83K 0.94% 26
2025
Q1
$4.37M Sell
20,853
-470
-2% -$98.5K 1.15% 22
2024
Q4
$3.79M Buy
21,323
+5,770
+37% +$1.03M 1.02% 26
2024
Q3
$3.07M Sell
15,553
-204
-1% -$40.3K 1.16% 20
2024
Q2
$2.7M Buy
15,757
+109
+0.7% +$18.7K 1.09% 24
2024
Q1
$2.85M Buy
15,648
+551
+4% +$100K 1.18% 24
2023
Q4
$2.34M Sell
15,097
-719
-5% -$111K 1.12% 24
2023
Q3
$2.36M Buy
15,816
+75
+0.5% +$11.2K 1.32% 23
2023
Q2
$2.12M Sell
15,741
-399
-2% -$53.8K 1.14% 26
2023
Q1
$2.57M Sell
16,140
-20
-0.1% -$3.19K 1.42% 17
2022
Q4
$2.61M Buy
16,160
+25
+0.2% +$4.04K 1.48% 16
2022
Q3
$2.17M Buy
16,135
+100
+0.6% +$13.4K 1.39% 17
2022
Q2
$2.46M Buy
16,035
+715
+5% +$109K 1.5% 14
2022
Q1
$2.48M Sell
15,320
-500
-3% -$81K 1.34% 18
2021
Q4
$2.14M Buy
+15,820
New +$2.14M 1.01% 24